Abstract:The clinical course of autoimmune and infectious disease varies greatly, even between individuals with the same condition. An understanding of the molecular basis for this heterogeneity could lead to significant improvements in both monitoring and treatment. During chronic infection the process of T-cell exhaustion inhibits the immune response, facilitating viral persistence. Here we show that a transcriptional signature reflecting CD8 T-cell exhaustion is associated with poor clearance of chronic viral infection, but conversely predicts better prognosis in multiple autoimmune diseases. The development of CD8 T-cell exhaustion during chronic infection is driven both by persistence of antigen and by a lack of accessory 'help' signals. In autoimmunity, we find that where evidence of CD4 T-cell co-stimulation is pronounced, that of CD8 T-cell exhaustion is reduced. We can reproduce the exhaustion signature by modifying the balance of persistent stimulation of T-cell antigen receptors and specific CD2-induced co-stimulation provided to human CD8 T cells in vitro, suggesting that each process plays a role in dictating outcome in autoimmune disease. The 'non-exhausted' T-cell state driven by CD2-induced co-stimulation is reduced by signals through the exhaustion-associated inhibitory receptor PD-1, suggesting that induction of exhaustion may be a therapeutic strategy in autoimmune and inflammatory disease. Using expression of optimal surrogate markers of co-stimulation/exhaustion signatures in independent data sets, we confirm an association with good clinical outcome or response to therapy in infection (hepatitis C virus) and vaccination (yellow fever, malaria, influenza), but poor outcome in autoimmune and inflammatory disease (type 1 diabetes, anti-neutrophil cytoplasmic antibody-associated vasculitis, systemic lupus erythematosus, idiopathic pulmonary fibrosis and dengue haemorrhagic fever). Thus, T-cell exhaustion plays a central role in determining outcome in autoimmune disease and targeted manipulation of this process could lead to new therapeutic opportunities.

Molecular and cellular insights into T cell exhaustion

Cellular and molecular waypoints along the path of T cell exhaustion

Exhausted T cells and epigenetic status

The current state and future of T-cell exhaustion research

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

Mechanisms of T cell exhaustion guiding next-generation immunotherapy

Clinical implications of T cell exhaustion for cancer immunotherapy

Epigenetics behind CD8 + T cell activation and exhaustion

Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming

CD8<SUP>+</SUP> T cell exhaustion in anti-tumour immunity: The new insights for cancer immunotherapy

CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy

gamma delta T cell exhaustion: Opportunities for intervention

T cell exhaustion in human cancers

Metabolic Plasticity and Regulation of T Cell Exhaustion

Regulatory Mechanisms and Reversal of CD8+T Cell Exhaustion: A Literature Review

Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment

CD8+ T Cell Exhaustion in Cancer

The Role of Exhausted T Cells in Tumor

Exhausted CD8 T Cells Downregulate the IL-18 Receptor and Become Unresponsive to Inflammatory Cytokines and Bacterial Co-infections

Bibliometric and visual analyses of trends in the field of T cell exhaustion research: Findings from 2000 to 2022